We are live on ! Find out more
TWST icon

Twist Bioscience

221 hedge funds and large institutions have $2.04B invested in Twist Bioscience in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

48% more call options, than puts

Call options by funds: $5.54M | Put options by funds: $3.73M

21% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 61

8% more funds holding

Funds holding: 204221 (+17)

2% more capital invested

Capital invested by funds: $2.01B → $2.04B (+$36M)

0.34% more ownership

Funds ownership: 103.14%103.48% (+0.34%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
221
Holders Change
+17
Holders Change %
+8.33%
% of All Funds
3.81%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
39
Increased
74
Reduced
61
Closed
19
Calls
$5.54M
Puts
$3.73M
Net Calls
+$1.81M
Net Calls Change
-$2.65M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$4.24M +$1.41M +33,202 +38%
FCM
52
Frontier Capital Management
Massachusetts
$4.21M +$5.08M +119,584 New
Ensign Peak Advisors
53
Ensign Peak Advisors
Utah
$4.17M +$1.99M +46,769 +65%
Barclays
54
Barclays
United Kingdom
$3.85M +$4.02M +94,574 +648%
CS
55
Candriam SCA
Luxembourg
$3.64M +$1.13M +26,519 +35%
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$3.15M +$3.24M +76,367 +593%
BPC
57
Banque Pictet & Cie
Switzerland
$3.14M +$746K +17,570 +25%
Legal & General Group
58
Legal & General Group
United Kingdom
$3.06M -$1.25M -29,544 -25%
Two Sigma Investments
59
Two Sigma Investments
New York
$3M +$3.61M +85,001 New
N
60
Natixis
France
$2.89M +$3.48M +82,060 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$2.75M +$217K +5,113 +7%
Ameriprise
62
Ameriprise
Minnesota
$2.73M -$103K -2,415 -3%
PI
63
Putnam Investments
Massachusetts
$2.66M +$120K +2,816 +4%
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$2.63M +$1.94M +45,731 +158%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.4M -$129K -3,036 -4%
ACM
66
Altium Capital Management
New York
$2.4M +$2.89M +68,000 New
Citadel Advisors
67
Citadel Advisors
Florida
$2.39M -$17.4M -410,309 -86%
RT
68
Rockland Trust
Massachusetts
$2.38M
SC
69
Slow Capital
California
$2.37M +$129K +3,035 +5%
HA
70
Homestead Advisers
Virginia
$2.18M
HF
71
HRT Financial
New York
$2.1M +$2.53M +59,536 New
Thrivent Financial for Lutherans
72
Thrivent Financial for Lutherans
Minnesota
$1.98M +$2.38M +56,139 New
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$1.97M +$127K +2,993 +6%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$1.92M +$163K +3,831 +8%
UBS AM
75
UBS AM
Illinois
$1.91M +$90.1K +2,121 +4%

TWST Hedge Fund Activity: Q3 2022 in Review

221 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2022, worth a combined $2.04B — up 1.8% from $2.01B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TWST positions and 19 closed out — a net gain of 20 holders — while 74 added to existing stakes and 61 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $65.3M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $54.5M sold.

  • 221 institutional investors held Twist Bioscience (TWST) as of Q3 2022, up from 204 in Q2 2022.
  • Funds reported $2.04B of Twist Bioscience stock for Q3 2022, up 1.8% quarter-over-quarter.
  • 39 funds opened new Twist Bioscience positions in Q3 2022 and 19 closed out, a net change of +20 holders.
  • The largest Twist Bioscience buyer in Q3 2022 was VOYA Investment Management, an estimated $65.3M added.
  • The largest Twist Bioscience seller in Q3 2022 was Allianz Asset Management, an estimated $54.5M sold.

Based on aggregated 13F filings for Q3 2022.